Harmony Biosciences names Takeda veteran Adam Zaeske as CCO; Dierks steps down

Harmony Biosciences Holdings, Inc.

Jeffrey Dierks steps down as CCO effective March 31, 2025; receives $476,215 cash and accelerated vesting for 2025 awards.
Adam Zaeske appointed as EVP and CCO effective March 31, 2025; previously Head of Central, South, and Eastern Europe at Takeda.
Zaeske managed a $2B business across 25 countries with 900 employees; delivered 3 consecutive years of double-digit growth.
Company reaffirms 2025 revenue guidance and states WAKIX is a $1B+ opportunity in adult narcolepsy alone.
Zaeske brings 25 years of pharma experience, including rare disease and neurology launches.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jeffrey Dierks

Chief Commercial Officer

HRMY · Harmony Biosciences Holdings, Inc.

Effective: 2025-03-31
Filed: March 24, 2025, 7:59 PM ET

Jeffrey Dierks will be departing from the Company as its Chief Commercial Officer, effective as of March 31, 2025 (the “Effective Date”), for personal reasons.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeffrey Dierks departed as Chief Commercial Officer at Harmony Biosciences Holdings, Inc..

Action: departing
Role: Chief Commercial Officer

Exact text from the filing

Jeffrey Dierks will be departing from the Company as its Chief Commercial Officer, effective as of March 31, 2025 (the “Effective Date”), for personal reasons.

View on SEC.gov

Harmony Biosciences Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-25-003502

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.